197 related articles for article (PubMed ID: 11731187)
1. Effective bleeding control and symptom relief by lower dose regimens of continuous combined hormone replacement therapy: a randomized comparative dose-ranging study.
Bruhat M; Rudolf K; Vaheri R; Kainulainen P; Timonen U; Viitanen A
Maturitas; 2001 Dec; 40(3):259-71. PubMed ID: 11731187
[TBL] [Abstract][Full Text] [Related]
2. A low-dose start in hormone replacement therapy provides a beneficial bleeding profile and few side-effects: randomized comparison with a conventional-dose regimen.
Mattsson LA; Skouby SO; Heikkinen J; Vaheri R; Mäenpää J; Timonen U
Climacteric; 2004 Mar; 7(1):59-69. PubMed ID: 15259284
[TBL] [Abstract][Full Text] [Related]
3. Endometrial safety and tolerability of triphasic sequential hormone replacement estradiol valerate/medroxyprogesterone acetate therapy regimen.
Rees MC; Kuhl H; Engelstein M; Mattila L; Mäenpää J; Mustonen M;
Climacteric; 2004 Mar; 7(1):23-32. PubMed ID: 15259280
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, multicentre study comparing the clinical effects of two sequential estradiol-progestin combinations containing either desogestrel or norethisterone acetate in climacteric women with estrogen deficiency symptoms.
Saure A; Hirvonen E; Milsom I; Christensen A; Damber MG
Maturitas; 1996 May; 24(1-2):111-8. PubMed ID: 8794442
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of two dosages of a continuous combined hormone replacement regimen.
Loh FH; Chen LH; Yu SL; Jorgensen LN
Maturitas; 2002 Feb; 41(2):123-31. PubMed ID: 11836043
[TBL] [Abstract][Full Text] [Related]
6. Postmenopausal uterine bleeding profiles with two forms of continuous combined hormone replacement therapy.
Johnson JV; Davidson M; Archer D; Bachmann G
Menopause; 2002; 9(1):16-22. PubMed ID: 11791082
[TBL] [Abstract][Full Text] [Related]
7. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S
Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025
[TBL] [Abstract][Full Text] [Related]
8. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
9. Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins.
Odmark IS; Bäckström T; Haeger M; Jonsson B; Bixo M
Maturitas; 2004 Jun; 48(2):137-46. PubMed ID: 15172088
[TBL] [Abstract][Full Text] [Related]
10. Intrauterine 10 microg and 20 microg levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: clinical, endometrial and metabolic response.
Raudaskoski T; Tapanainen J; Tomás E; Luotola H; Pekonen F; Ronni-Sivula H; Timonen H; Riphagen F; Laatikainen T
BJOG; 2002 Feb; 109(2):136-44. PubMed ID: 11888095
[TBL] [Abstract][Full Text] [Related]
11. Bleeding patterns in peri and postmenopausal women taking a continuous combined regimen of estradiol with norethisterone acetate or a conventional sequential regimen of conjugated equine estrogens with medrogestone.
von Holst T; Lang E; Winkler U; Keil D
Maturitas; 2002 Dec; 43(4):265-75. PubMed ID: 12468135
[TBL] [Abstract][Full Text] [Related]
12. Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women.
Tilly-Kiesi M; Kahri J; Pyörälä T; Puolakka J; Luotola H; Lappi M; Lahdenperä S; Taskinen MR
Atherosclerosis; 1997 Mar; 129(2):249-59. PubMed ID: 9105568
[TBL] [Abstract][Full Text] [Related]
13. Do combinations of 1 mg estradiol and low doses of NETA effectively control menopausal symptoms?
Baerug U; Winge T; Nordland G; Faber-Swensson E; Heldaas K; Norling B; Larsen S; Arce JC
Climacteric; 1998 Sep; 1(3):219-28. PubMed ID: 11907946
[TBL] [Abstract][Full Text] [Related]
14. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
Johannisson E; Holinka CF; Arrenbrecht S
Int J Fertil Womens Med; 1997; 42 Suppl 2():388-98. PubMed ID: 9397386
[TBL] [Abstract][Full Text] [Related]
15. Intermittent progestin administration as part of hormone replacement therapy: long-term comparison between estradiol 1 mg combined with intermittent norgestimate and estradiol 2 mg combined with constant norethisterone acetate.
Ylikorkala O; Wahlström T; Caubel P; Lane R
Acta Obstet Gynecol Scand; 2002 Jul; 81(7):654-60. PubMed ID: 12190841
[TBL] [Abstract][Full Text] [Related]
16. Impact on uterine bleeding and endometrial thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy.
Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
Menopause; 1999; 6(4):299-306. PubMed ID: 10614676
[TBL] [Abstract][Full Text] [Related]
17. Changes in normal lipid profile of menopausal women with combined hormone replacement therapy. Comparative clinical trial of two hormonal combinations (conjugated estrogens/medroxyprogesterone acetate versus estradiol valerate/cyproterone acetate).
Alwers R; Urdinola J; Onatra W; Sánchez F; Posso H
Maturitas; 1999 May; 32(1):41-50. PubMed ID: 10423715
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, randomized, comparative study evaluating clinical effects of two sequential estradiol-progestogen combinations containing either desogestrel or medroxyprogesterone acetate in climacteric women.
Saure A; Planellas J; Poulsen HK; Jaszczak P
Maturitas; 2000 Feb; 34(2):133-42. PubMed ID: 10714908
[TBL] [Abstract][Full Text] [Related]
19. Climodien (estradiol valerate 2 mg plus dienogest 2 mg) is safe and effective in the treatment of postmenopausal complaints.
Gräser T; Römer T; Wiedey KD; Janaud A
Climacteric; 2001 Dec; 4(4):332-42. PubMed ID: 11770190
[TBL] [Abstract][Full Text] [Related]
20. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
